Department of Veterans Affairs releases COVID-19 response plan

Mar 27, 2020 - 04:27 PM
COVID19 Web Sized

The Department of Veterans Affairs has released a comprehensive plan to respond to COVID-19.

"The primary goal of the operations plan is to protect Veterans and staff from acquiring COVID-19 infection by leveraging technology, communications as well as using dedicated staff and space to care for COVID-19 patients,” the report said. VA said it will create a safe environment by implementing a system where one VA facility operates as two separate “zones” (Standard and COVID-19) for inpatient care. VA will provide most outpatient care for veterans through telehealth services as appropriate. “This approach minimizes the risk of infection, supports expansion to meet an increasing need for COVID-19 services, and provides Veterans in routine VA care consistent access to VA care,” according to the report.

The plan also includes strategies to address a large number of COVID-19 cases to include alternative sites of care for veterans with COVID-19. See the full report and the latest VA COVID-19 updates.

Related News Articles

Headline
FDA approves first point-of-care antibody test
The Food and Drug Administration today authorized for emergency use the first serology test to help identify individuals with antibodies to SARS-CoV-2 at the…
Headline
Clinical trials to test convalescent plasma in hospital patients expanding
Two clinical trials launched in April to evaluate convalescent plasma as a treatment for patients hospitalized with COVID-19 are expanding, the National…
Headline
States in Medicaid community care demonstration eligible for more funding
The Centers for Medicare & Medicaid Services today announced $165 million in supplemental funding to help 33 states participating in the Money Follows…
Headline
CDC awards $200 million to help jurisdictions plan for COVID-19 vaccine
The Centers for Disease Control and Prevention today awarded $200 million in Coronavirus Aid, Relief, and Economic Security Act funds to help states,…
Headline
Johnson & Johnson COVID-19 vaccine candidate moves forward to phase 3
Johnson & Johnson today said  that its COVID-19 vaccine candidate is moving to a global phase 3 clinical trial. The JNJ-78436735 vaccine candidate,…
Headline
House leadership urged to address impending MACRA changes
Nearly 30 representatives yesterday urged House leaders to modify in the next COVID-19 response package impending thresholds for qualifying participants in…